Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration
- PMID: 38961512
- PMCID: PMC11220971
- DOI: 10.1186/s13195-024-01510-y
Identifying longitudinal cognitive resilience from cross-sectional amyloid, tau, and neurodegeneration
Abstract
Background: Leveraging Alzheimer's disease (AD) imaging biomarkers and longitudinal cognitive data may allow us to establish evidence of cognitive resilience (CR) to AD pathology in-vivo. Here, we applied latent class mixture modeling, adjusting for sex, baseline age, and neuroimaging biomarkers of amyloid, tau and neurodegeneration, to a sample of cognitively unimpaired older adults to identify longitudinal trajectories of CR.
Methods: We identified 200 Harvard Aging Brain Study (HABS) participants (mean age = 71.89 years, SD = 9.41 years, 59% women) who were cognitively unimpaired at baseline with 2 or more timepoints of cognitive assessment following a single amyloid-PET, tau-PET and structural MRI. We examined latent class mixture models with longitudinal cognition as the dependent variable and time from baseline, baseline age, sex, neocortical Aβ, entorhinal tau, and adjusted hippocampal volume as independent variables. We then examined group differences in CR-related factors across the identified subgroups from a favored model. Finally, we applied our favored model to a dataset from the Alzheimer's Disease Neuroimaging Initiative (ADNI; n = 160, mean age = 73.9 years, SD = 7.6 years, 60% women).
Results: The favored model identified 3 latent subgroups, which we labelled as Normal (71% of HABS sample), Resilient (22.5%) and Declining (6.5%) subgroups. The Resilient subgroup exhibited higher baseline cognitive performance and a stable cognitive slope. They were differentiated from other groups by higher levels of verbal intelligence and past cognitive activity. In ADNI, this model identified a larger Normal subgroup (88.1%), a smaller Resilient subgroup (6.3%) and a Declining group (5.6%) with a lower cognitive baseline.
Conclusion: These findings demonstrate the value of data-driven approaches to identify longitudinal CR groups in preclinical AD. With such an approach, we identified a CR subgroup who reflected expected characteristics based on previous literature, higher levels of verbal intelligence and past cognitive activity.
Keywords: Alzheimer’s disease; Amyloid; Cognition; Cognitive Reserve; Cognitive Resilience; Longitudinal analysis; MRI; PET; Tau.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease.JAMA Neurol. 2022 Jun 1;79(6):592-603. doi: 10.1001/jamaneurol.2022.0676. JAMA Neurol. 2022. PMID: 35435938 Free PMC article.
-
Study Partner Report of Apathy in Older Adults is Associated with AD Biomarkers: Findings from the Harvard Aging Brain Study.Am J Geriatr Psychiatry. 2024 Aug;32(8):909-919. doi: 10.1016/j.jagp.2024.01.020. Epub 2024 Jan 28. Am J Geriatr Psychiatry. 2024. PMID: 38443298 Free PMC article.
-
Impact of diabetes on the progression of Alzheimer's disease via trajectories of amyloid-tau-neurodegeneration (ATN) biomarkers.J Nutr Health Aging. 2025 Feb;29(2):100444. doi: 10.1016/j.jnha.2024.100444. Epub 2024 Dec 10. J Nutr Health Aging. 2025. PMID: 39662155 Free PMC article.
-
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2. Cochrane Database Syst Rev. 2017. PMID: 28328043 Free PMC article.
-
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2015 Jan 28;1(1):CD010632. doi: 10.1002/14651858.CD010632.pub2. Cochrane Database Syst Rev. 2015. PMID: 25629415 Free PMC article.
Cited by
-
Neighborhood deprivation moderates prognosis in behavioral-variant frontotemporal degeneration.medRxiv [Preprint]. 2025 May 13:2025.05.12.25327099. doi: 10.1101/2025.05.12.25327099. medRxiv. 2025. PMID: 40463548 Free PMC article. Preprint.
-
Synapse vulnerability and resilience across the clinical spectrum of dementias.Nat Rev Neurol. 2025 Jul;21(7):353-369. doi: 10.1038/s41582-025-01094-7. Epub 2025 May 22. Nat Rev Neurol. 2025. PMID: 40404832 Review.
References
-
- Bocancea DI, van Loenhoud AC, Groot C, Barkhof F, van der Flier WM, Ossenkoppele R. Measuring Resilience and Resistance in Aging and Alzheimer Disease Using Residual Methods: A Systematic Review and Meta-analysis. Neurology. 2021;97(10):474–488. doi: 10.1212/WNL.0000000000012499. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous